[go: up one dir, main page]

AR108885A2 - Método para la elaboración de escitalopram - Google Patents

Método para la elaboración de escitalopram

Info

Publication number
AR108885A2
AR108885A2 ARP170101761A ARP170101761A AR108885A2 AR 108885 A2 AR108885 A2 AR 108885A2 AR P170101761 A ARP170101761 A AR P170101761A AR P170101761 A ARP170101761 A AR P170101761A AR 108885 A2 AR108885 A2 AR 108885A2
Authority
AR
Argentina
Prior art keywords
benzonitrile
hydroxybutyl
fluorophenyl
hydroxymethyl
dimethylamino
Prior art date
Application number
ARP170101761A
Other languages
English (en)
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR108885(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of AR108885A2 publication Critical patent/AR108885A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se revela un método para la resolución de 4-[4-(dimetilamino)-1-(4’-fluorofenil)-1-hidroxibutil]-3-(hidroximetil)-benzonitrilo como una mezcla racémica o no racémica de enantiómeros, en sus enantiómeros aislados, donde dicho método comprende la etapa de la cristalización fraccional de 4-[4-(dimetilamino)-1-(4’-fluorofenil)-1-hidroxibutil]-3-(hidroximetil)-benzonitrilo como una sal, con el enantiómero (+)-(S,S)- o (-)-(R,R)- de ácido O,O’-di-p-toluoil-tartárico, en un sistema de solvente que comprende 1-propanol, etanol o acetonitrilo.
ARP170101761A 2007-09-11 2017-06-26 Método para la elaboración de escitalopram AR108885A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200701314 2007-09-11

Publications (1)

Publication Number Publication Date
AR108885A2 true AR108885A2 (es) 2018-10-03

Family

ID=39735675

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP080103832A AR068174A1 (es) 2007-09-11 2008-09-03 Metodo para la elaboracion de escitalopram por resolucion en sus enantiomeros
ARP170101761A AR108885A2 (es) 2007-09-11 2017-06-26 Método para la elaboración de escitalopram

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP080103832A AR068174A1 (es) 2007-09-11 2008-09-03 Metodo para la elaboracion de escitalopram por resolucion en sus enantiomeros

Country Status (52)

Country Link
EP (2) EP2397461A1 (es)
JP (1) JP4966933B2 (es)
KR (1) KR101054224B1 (es)
CN (1) CN101386583A (es)
AR (2) AR068174A1 (es)
AT (2) ATE518829T1 (es)
AU (1) AU2008212055C1 (es)
BE (1) BE1017548A6 (es)
BG (1) BG110206A (es)
BR (1) BRPI0804121B1 (es)
CA (1) CA2638499C (es)
CH (1) CH697885B1 (es)
CL (1) CL2008002686A1 (es)
CO (1) CO6140012A1 (es)
CY (2) CY2600B1 (es)
CZ (1) CZ2008537A3 (es)
DE (1) DE102008046530A1 (es)
DK (2) DK2061753T3 (es)
EA (1) EA012787B1 (es)
EE (1) EE00864U1 (es)
ES (2) ES2368294T3 (es)
FI (1) FI121570B (es)
FR (1) FR2920766A1 (es)
GB (1) GB2448848B (es)
GR (1) GR1006595B (es)
HR (2) HRP20080425A2 (es)
HU (1) HUP0800549A2 (es)
IE (1) IES20080708A2 (es)
IL (1) IL193845A (es)
IS (1) IS8758A (es)
LT (1) LT5577B (es)
LU (1) LU91479B1 (es)
LV (1) LV13813B (es)
ME (1) ME00176B (es)
MX (1) MX2008011451A (es)
MY (1) MY144210A (es)
NL (1) NL2001953C2 (es)
NO (1) NO20083756L (es)
NZ (1) NZ570884A (es)
PL (2) PL386026A1 (es)
PT (2) PT104169A (es)
RO (1) RO125301A2 (es)
RS (2) RS20080401A (es)
SE (1) SE533041C2 (es)
SG (1) SG151195A1 (es)
SI (2) SI22567A2 (es)
SK (1) SK500302008A3 (es)
TR (2) TR200907629A2 (es)
TW (1) TWI391383B (es)
UA (2) UA41919U (es)
WO (1) WO2009033488A1 (es)
ZA (1) ZA200807753B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939680B2 (en) 2005-07-27 2011-05-10 Aurobindo Pharma Ltd. Process for the preparation of Escitalopram
CN102796065A (zh) * 2011-05-27 2012-11-28 江苏豪森医药集团连云港宏创医药有限公司 一种制备光学纯度高的艾司西酞普兰的方法
CN104119240A (zh) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 (S)-(-)-α-甲胺基苯丙酮的制备方法
CN103497145B (zh) * 2013-10-10 2016-01-27 南昌大学 一种光学纯多奈哌齐的制备工艺
CN104119248A (zh) * 2014-08-08 2014-10-29 广东东阳光药业有限公司 S-西酞普兰的制备方法
US10287240B2 (en) 2014-11-14 2019-05-14 Zhejiang Hushai Pharmaceuticals Co., Ltd. Method for resolution of citalopram intermediate 5-cyano diol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
NZ540653A (en) 2002-12-23 2008-02-29 Lundbeck & Co As H A process for the preparation of racemic citalopram diol and/or S- or R- citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram
AU2003242990A1 (en) * 2003-01-17 2004-08-13 Pulla Reddy Muddasani Processes for the preparation of escitalopram and its precursor
CA2575975A1 (en) * 2003-11-12 2005-05-26 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
WO2006106531A1 (en) * 2005-04-04 2006-10-12 Jubilant Organosys Ltd Process for the preparation of escitalopram or its acid addition salts
US7939680B2 (en) * 2005-07-27 2011-05-10 Aurobindo Pharma Ltd. Process for the preparation of Escitalopram

Also Published As

Publication number Publication date
ME00176B (me) 2011-02-10
LT5577B (lt) 2009-06-25
BE1017548A6 (fr) 2008-11-04
NZ570884A (en) 2010-03-26
CN101386583A (zh) 2009-03-18
ZA200807753B (en) 2009-04-29
EP2061753A1 (en) 2009-05-27
TR200806903A2 (tr) 2009-03-23
FI20085807L (fi) 2009-03-12
ATE518829T1 (de) 2011-08-15
AU2008212055A1 (en) 2009-03-26
LT2008068A (en) 2009-03-25
AR068174A1 (es) 2009-11-11
CL2008002686A1 (es) 2009-01-02
RS20080401A (sr) 2010-03-02
SI22567A2 (sl) 2008-12-31
BRPI0804121A2 (pt) 2009-09-29
JP4966933B2 (ja) 2012-07-04
SK500302008A3 (sk) 2009-04-06
RO125301A2 (ro) 2010-03-30
BRPI0804121B1 (pt) 2022-04-12
UA43461U (uk) 2009-08-25
AU2008212055C1 (en) 2011-06-02
WO2009033488A1 (en) 2009-03-19
AU2008212055B2 (en) 2010-08-12
EE00864U1 (et) 2009-10-15
IS8758A (is) 2009-03-12
FI121570B (fi) 2011-01-14
HU0800549D0 (en) 2008-10-28
NL2001953A1 (nl) 2008-12-22
EA200801797A3 (ru) 2009-02-27
RS51909B (sr) 2012-02-29
LV13813B (en) 2008-11-20
SG151195A1 (en) 2009-04-30
LU91479B1 (fr) 2010-03-11
DK177075B1 (da) 2011-06-14
MX2008011451A (es) 2009-03-10
TW200906814A (en) 2009-02-16
TR200907629A2 (tr) 2009-11-23
BRPI0804121A8 (pt) 2021-04-13
HUP0800549A2 (en) 2009-03-02
ES2334875B1 (es) 2010-10-27
FI20085807A0 (fi) 2008-08-29
SE0801929L (sv) 2009-03-12
EA012787B1 (ru) 2009-12-30
ES2334875A1 (es) 2010-03-16
GR1006595B (el) 2009-11-16
GB0815773D0 (en) 2008-10-08
CA2638499A1 (en) 2008-11-21
MEP10108A (bs) 2010-10-10
CY1111924T1 (el) 2015-11-04
JP2009149600A (ja) 2009-07-09
EP2061753B1 (en) 2011-08-03
GR20080100581A (el) 2009-04-30
NL2001953C2 (en) 2009-05-07
SI2061753T1 (sl) 2011-10-28
KR101054224B1 (ko) 2011-08-08
IES20080708A2 (en) 2009-03-18
GB2448848B (en) 2011-01-26
PL386026A1 (pl) 2009-02-16
CZ2008537A3 (cs) 2009-03-18
TWI391383B (zh) 2013-04-01
PT104169A (pt) 2009-02-02
BG110206A (en) 2009-03-31
UA41919U (uk) 2009-06-10
CH697885B1 (de) 2009-03-13
PL2061753T3 (pl) 2011-12-30
HRP20110636T1 (hr) 2011-10-31
HRP20080425A2 (hr) 2010-04-30
CO6140012A1 (es) 2010-03-19
FR2920766A1 (fr) 2009-03-13
EA200801797A2 (ru) 2008-12-30
SE533041C2 (sv) 2010-06-15
DE102008046530A1 (de) 2009-03-19
MY144210A (en) 2011-08-15
EP2397461A1 (en) 2011-12-21
IL193845A (en) 2011-03-31
AT10984U1 (de) 2010-02-15
DK2061753T3 (da) 2011-09-26
NO20083756L (no) 2009-03-12
GB2448848A (en) 2008-10-29
CY2600B1 (en) 2010-03-03
DK200801265A (en) 2009-03-12
PT2061753E (pt) 2011-09-14
KR20090027185A (ko) 2009-03-16
ES2368294T3 (es) 2011-11-16
CA2638499C (en) 2010-09-28

Similar Documents

Publication Publication Date Title
AR108885A2 (es) Método para la elaboración de escitalopram
ES2526555T3 (es) Composición fungicida y método para controlar enfermedades de plantas
ATE455752T1 (de) Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin
ATE515491T1 (de) Herstellung von 3-ä(1r,2r)-3-(dimethylamino)- 1ethyl-2-methylpropylüphenol
CY1112283T1 (el) Μεθοδος για την παρασκευη 17-βινυλ-τριφλικων ως ενδιaμεσα
EP3868739C0 (en) PROCESS FOR PREPARING (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL
CR10156A (es) Metodos para preparar alcoholes sulfonamida sustituidos e intermediarios de estos
AR068403A1 (es) Proceso e intermediarios para la preparacion de inhibidores de integrasa
BRPI0918460A2 (pt) dispositivo de espectrômetro de massa - cromatografia líquida, emissor para um fluxo nanoescala, método para fabricar uma coluna de cromatografia líquida, para identificar um epítopo, e para produzir uma composição que compreende um epítodo, uso do dispositivo, epítopo, e, uso de um epítopo.
ES2130079A1 (es) Resolucion de aminas
ES2567159T3 (es) Método para la deshidratación de alcoholes grasos
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
AR048832A1 (es) Tratamiento de soporte de enfermedades hepaticas
Lee et al. Formal Synthesis of Fesoterodine by Acid‐Facilitated Aromatic Alkylation
EA201071025A1 (ru) Способ получения [фенилсульфанилфенил]пиперидинов
GT200600102A (es) Procedimiento para la preparacion de compuestos benzoxazol sustituidos
BRPI0508808A (pt) processo quimio-enzimático para preparar escitalopram
CO6491120A2 (es) Metodo para resolucion de una mezcla de isomeros opticos de pinocembrina especialemente un racemato de pinocembrina
CL2009001437A1 (es) Metodo para la preparacion de (1r, 2s, 3r)-1-(2-(isoxazol-3-il)-1h-imidazol-5-il)butano-1,2,3,4-tetraol utilizando isoxazol-3-carbonitrilo; y uno de los compuestos intermediarios considerados en la preparacion del isoxazol-3-carbonitrilo.
ATE534639T1 (de) Verfahren zur lösung von citalopram
CL2007001498A1 (es) Metodo para la preparacion de 2-(3-(hidroximetil)-6-nitro- 2,3-dihidrobenzo[b][1,4]dioxin-5-il)acetonitrilo.
WO2006127331A3 (en) Conversion process for 2,3-benzodiazepine enantiomers
SE9801726D0 (sv) New process
DE602005025912D1 (de) Neues verfahren zur herstellung von 3-ä5'-(3,4-bis-hydroxymethyl-benzyloxy)-2'- ethyl-2-propyl-biphenyl-4-ylü-penta-3-ol

Legal Events

Date Code Title Description
FB Suspension of granting procedure